The latest directive by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to ban all herbal medicines without registration or a product license is likely to affect the Rs 850-crore annual sales of Indian herbal and Ayurvedic medicines in Europe. The deadline for registration was